We are live on ! Find out more
WINT

Windtree Therapeutics
WINT

Delisted

WINT was delisted on the 20th of August, 2025.

Back to rankings

6 hedge funds and large institutions have $3.33M invested in Windtree Therapeutics in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $3.17M → $3.33M (+$164K)

0% more funds holding

Funds holding: 6 → 6 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
$2.31M
Puts
–
Net Calls
+$2.31M
Net Calls Change
+$2.31M

Top Buyers

1
TI
tru Independence
Oregon
+$277K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$277K
2
PP
Paloma Partners
Connecticut
-$277K
3
Goldman Sachs
Goldman Sachs
New York
-$60K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.42M – – –
Millennium Management
2
Millennium Management
New York
$552K -$277K -1 -33%
KC
3
Kepos Capital
New York
$462K – – –
Northern Trust
4
Northern Trust
Illinois
$371K – – –
FWM
5
Frontier Wealth Management
Missouri
$308K – – –
DM
6
Deerfield Management
New York
$103K – – –
PP
7
Paloma Partners
Connecticut
$95K -$277K -1 Closed
TRCT
8
Tower Research Capital (TRC)
New York
$19K – – –
UBS Group
9
UBS Group
Switzerland
$2K – – –
TI
10
tru Independence
Oregon
$308 +$277K +1 New
Goldman Sachs
11
Goldman Sachs
New York
– -$60K – –